The consortium ultimately aims to establish a sustainably funded infrastructure for biological information in Europe, to support innovation in life science research, knowledge generation and its translation to medicine, the environment, the bio-industries and society.
Since the 1980s, the storage mechanism for biological information has gone from being an individual’s notebook and published academic papers to open source databases of integrated information exchanged worldwide on a daily basis. This information and the databases that make it available to scientists around the world are an indispensable resource for modern biology. Yet commonly these resources are dependent on insecure or short term funding, meaning that the valuable data they contain and provide access to, are jeopardised when funding ends.
ELIXIR aims to protect the existing and future data held in biological data resources. The project will work to provide a European infrastructure for optimal information storage, access and integration supported by a secure funding mechanism. "Under the Framework Programme for Research, the European Commission provides support to the preparatory phase for the construction of new research infrastructures,” commented Mr Robert-Jan Smits, Director of Directorate B (European Research Area: Research Programmes and Capacity) at DG Research of the European Commission. “This will help catalyse the efforts and resources needed to build and ensure the sustainability of large-scale, word-class infrastructures needed by Europe's research communities." In this way, the longevity of Europe’s central molecular data resources will be guaranteed.
The development of such a network is a strategic step in maintaining the global position of Europe as a leader in scientific research. “The biological sciences are delivering benefits that contribute to advances in our society,” says EMBL-EBI director and ELIXIR coordinator Janet Thornton. “Developing a securely funded, integrative infrastructure will give Europe one voice in the global community, meaning that we can make connections and realise those benefits more quickly by working together,” she concludes.
More information on ELIXIR and details on future stakeholder meetings can be found at www.elixir-europe.org
Louisa Wright | alfa
Gold nanoclusters: new frontier for developing medication for treatment of Alzheimer's disease
17.02.2020 | Science China Press
Catalyst deposition on fragile chips
17.02.2020 | Ruhr-University Bochum
Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.
Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...
Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices
The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...
Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.
Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.
After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.
"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.
Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected
Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...
12.02.2020 | Event News
16.01.2020 | Event News
15.01.2020 | Event News
17.02.2020 | Life Sciences
17.02.2020 | Information Technology
17.02.2020 | Life Sciences